Epipen Jr. (2017-03-31)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| B. 5GU763 | B. Epipen Jr. (.3 mg) | - Recalling Firm
- Pfizer Canada Inc.
- 17300 Trans-Canada Hwy.
- Kirkland
- H9J 2M5
- Ontario
- CANADA
- Marketing Authorization Holder
- Mylan Specialty LP
- 781 Chestnut Ridge Road
- Morgantown
- 26504-4310
- West Virginia
- UNITED STATES
| B. sterile liquid for injection | B. DIN 00509558 | B. 0.3 mg epinephrine |
| A. 5GR765 | A. Epipen Jr. (.15 mg) | - Recalling Firm
- Pfizer Canada Inc.
- 17300 Trans-Canada Hwy.
- Kirkland
- H9J 2M5
- Ontario
- CANADA
- Marketing Authorization Holder
- Mylan Specialty LP
- 781 Chestnut Ridge Road
- Morgantown
- 26504-4310
- West Virginia
- UNITED STATES
| A. Sterile liquid for injection | DIN 00578657 | A. 0.15 mg epinephrine |
Affected Products
A. Epipen Jr. (.15 mg)
B. Epipen (.3 mg)
Malfunction of the affected lots' auto-injector that may impact dispensing of the product